The Development and Future Perspectives of Cancer Vaccines
DOI:
https://doi.org/10.61173/5fma8z09Keywords:
Cancer Vaccines, Tumor-Associated Antigens, ImmunotherapiesAbstract
The invention and application of vaccines are remarkable progress in the approach of defense against diseases. Due to vaccines, in addition to treatment after infection, the strategies for curing have expanded to prior prevention. Cancer vaccines are cancer immunotherapies that trigger artificial immune responses against TAAs and TSAs to utilize immune memory to attack and destroy malignant tumor cells. Although cancer vaccines, which utilize the immune system to maintain the inner balance of the human body, are revolutionary compared to conventional chemotherapy, the variety of TAAs and TSAs, systemic toxicity, and low immunogenicity of tumor antigens have hindered cancer vaccines’ clinical use. This paper gives a brief review of cancer vaccines along with other immunotherapy methods. It will investigate the types, development, and mechanism of cancer vaccines and other immunotherapy. It will also compare cancer vaccines with other cancer immunotherapies and discuss the prospects of cancer immunotherapies. Cancer vaccine has a huge potential to control the development of cancer. This paper hopes to summarize and review the future trend of cancer therapeutics and promote the acquaintance with cancer vaccines.
References
[1] WHO(2021). Vaccines and immunization: What is vaccination? https://www.who.int/news-room/questions-andanswers/item/vaccines-and-immunization-what-is-vaccination
[2] WHO(2021).Cancer. https://www.who.int/news-room/factsheets/detail/cancer
[3] Jennifer Couzin-Frankel , Cancer Immunotherapy. Science342,1432-1433(2013).
[4] Saha T, Dash C, Jayabalan R, Khiste S, Kulkarni A, Kurmi K, Mondal J, Majumder P.K., Bardia A, Jang HL, Sengupta S. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat Nanotechnol. 2022 Jan;17(1):98-106.
[5] Russell, S., Peng, KW. & Bell, J. Oncolytic virotherapy. Nat Biotechnol 30, 658–670 (2012).
[6] Abbott M, Ustoyev Y. Cancer and the Immune System: The History and Background of Immunotherapy. Semin Oncol Nurs. 2019 Oct;35(5):150923.
[7] Fukuhara H, Ino Y, Todo T. Oncolytic virus therapy: a new era of cancer treatment at dawn. Cancer Sci. 2016;107:1373–1379.
[8] Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumorinfiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020 Aug;17(8):807-821.
[9] Oiseth SJ, Aziz MS. Cancer immunotherapy: a brief review of the history, possibili ties, and challenges ahead. J Cancer Metastasis Treat. 2017;3:250–261.
[10] Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887–3895 (1992).
[11] Pardoll D. Cancer and the immune system: basic concepts and targets for interven tion. Semin Oncol. 2015;42:523–538.
[12] Tran, T., Blanc, C., Granier, C. et al. Therapeutic cancer vaccine: building the future from lessons of the past. Semin Immunopathol 41, 69–85 (2019).
[13] Coley W. B. II. Contribution to the knowledge of sarcoma. Annals of Surgery. 1891;14(3):199–220.
[14] Morales A, Eidinger D, Bruce AW. Intracavity Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116:180–182.
[15] Liu J, Fu M, Wang M, Wan D, Wei Y, Wei X. Cancer vaccines as promising immuno-therapeutics: platforms and current progress. J Hematol Oncol (2022)15:28.
[16] Vishweshwaraiah YL, Dokholyan NV. mRNA vaccines for cancer immunotherapy. Front Immunol. 2022 Dec 14;13:1029069.
[17] Igarashi Y, Sasada T. Cancer vaccines: Toward the next breakthrough in cancer immunotherapy. J Immunol Res (2020) 2020:5825401.
[18] Santos PM, Butterfield LH. Dendritic cell–based cancer vaccines. J Immunol (2018) 200:443 L.P. – 449.
[19] Paston SJ, Brentville VA, Symonds P, Durrant LG. Cancer vaccines, adjuvants, and delivery systems. Front Immunol (2021) 12:627932
[20] Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321–330 (2019)
[21] Dmitry Dorofeev, B.S. Hot vs Cold: the differences between tumor types. https://www.news-medical.net/health/Hot-vs-Coldthe-differences-between-tumor-types.aspx
[22] Bai H, Lester GMS, Petishnok LC, Dean DA. Cytoplasmic transport and nuclear import of plasmid DNA. Biosci Rep (2017) 37.
[23] Huff AL, Jaffee EM, Zaidi N. Messenger RNA Vaccines for Cancer Immunotherapy: Progress Promotes Promise. J Clin Invest (2022) 132(6)
[24] Duan LJ, Wang Q, Zhang C, Yang DX, Zhang XY. Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy. Front Immunol. 2022 May 26;13:923647.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
